Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Tiny guillotine decapitates mosquitoes to fight malaria, new antibody approach to tackling Ebola, and faster and cheaper test to detect Zika

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

PATH
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
The beginning of the end

Phil Carroll, senior policy communications associate at PATH, writes about Marc LaForce, recently retired director of the Meningitis Vaccine Project. This post is part of an ongoing effort on Breakthroughs to highlight leaders and heroes in global health research and development (R&D).

PATH
Read More
USAID’s Shah continues leadership in science and innovation

Late last week, USAID Administrator Rajiv Shah released his second annual letter, outlining major issues and initiatives that have shaped the agency since its inception 50 years ago.

GHTC
Read More
A technological renaissance for girls and women

Janna Oberdorf, Director of Communications and Outreach for Women Deliver, writes about the recent “Women Deliver 50” initiative to mark International Women’s Day.

Women Deliver
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Women at the Forefront of AIDS Vaccine Research

Dr. Gaudensia Nzembi Mutua is a research physician at the Kenya AIDS Vaccine Initiative (KAVI). She is based in Nairobi, Kenya. This post originally appeared on the ONE blog.

Kenya AIDS Vaccine Initiative
Read More
Health R&D in New York: Extending lives and driving the economy

Research!America, a member of the GHTC, recently conducted analyses in target states to measure the health and economic impact of global health research and development (R&D), highlighting its benefits for states across the nation and strengthening the evidence base for Congress’ support of federal investments in global health R&D. This is the sixth and last post in a series.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
GHTC
Global Health R&D: A Smart Investment for the US

After attending GHTC’s annual briefing yesterday, it is nearly impossible, and arguably fully impossible, to come up with any reason as to why the US should not invest in global health research and development (R&D).

GHTC
Read More
PATH/Heng Chivoan
US senator on global health: ‘Achievable stuff’

For those in the global health world—and there are many in the nation’s capital—one common question is why in tight budgetary times should Congress support spending on research and development (R&D) to fight diseases around the world.

Read More
PATH/Aaron Joel Santos
GHTC’s annual policy report: How the US can help sustain incredible progress in global health research

Today, the GHTC will release our third annual policy report. This year’s report will continue the tradition for which we’ve become known in the world of global health research and product development—releasing recommendations for how US policymakers can continue to advance innovation and save lives around the world.

GHTC
Read More
PATH/Eric Becker
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
OWH’s treatment for kala-azar gains registration in Nepal

GHTC member OneWorld Health (OWH) recently announced that its treatment for kala-azar, or leishmaniasis, was registered for use in Nepal. In this guest post, OWH explains why this announcement is so significant for global health.

Read More
PATH/Evelyn Hockstein
Global health R&D in New Jersey: Building on strong private-sector investment

When people think of hotspots for global health R&D, the state of New Jersey may not immediately come to mind. But it should. Despite ranking eleventh in population size, New Jersey ranks third in R&D investment among states, thanks mainly to robust private-sector investment.

Research!America
Read More
PATH/Gabe Bienczycki
Fighting TB in India, one lab at a time

India is a country that changes dramatically from place to place, something I experienced firsthand while on a two week trip there this past fall.

PATH
Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Evelyn Hockstein
Global health R&D: A smart investment for Illinois

“The world is interconnected, and that demands an integrated approach to global health,” President Obama stated when he announced the US Global Health Initiative on May 5, 2009.

Research!America
Read More
Obama’s FY 2013 budget request raises concerns for global health R&D

On Monday, President Obama released his Administration’s much-anticipated FY 2013 budget request to mixed reviews. In his introduction to the overall budget request, Obama emphasized that research and development (R&D) programs are essential to the US economy and the country’s future.

GHTC
Read More
PATH/Patrick McKern
US Government launches new initiatives to spur innovation for global development

Ashley Bennett, senior policy associate at the GHTC, writes about the new programs announced at a White House event on Wednesday to promote innovation in global development.

GHTC
Read More
Patents for Humanity

David Kappos is the Director of the US Patent and Trademark Office (USPTO). On Wednesday, USPTO announced the Patents for Humanity pilot program, which rewards patent owners for using their patented technology to address humanitarian needs, including global health and medical technologies. The program was announced at a White House event on innovation for international development. This post originally appeared on the USPTO blog.

Read More